Article Abstract

Non-invasive assessment for alpha-1 antitrypsin deficiency- associated liver disease: new insights on steatosis and fibrosis in Pi*ZZ carriers

Authors: Siyer Roohani, Frank Tacke


One in every 5,000 individuals is expected to be affected by the hereditary alpha-1 antitrypsin deficiency (AATD) predisposing to liver cirrhosis, hepatocellular carcinoma and chronic obstructive pulmonary disease (COPD).

Article Options

Download Citation